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ABSTRACT
The colon cancer (CC) is the fourth most common cancer in the world. It is associated with metastatic spread in 50% of cases 
in the course of the disease. Common sites for synchronous metastases from colorectal cancer are the lung, liver, perito-
neum, bone and brain. The frequency of ovarian metastasis from CC varies widely from 1.6 to 7.4%. This type of metastasis 
is difficult to distinguish clinically from primary ovarian neoplasms. We present a case of a 49-years old woman admitted to 
the Department of General Surgery at the 5th Military Clinical Hospital in Cracow for elective surgery for metastatic obstruc-
tive sigmoid cancer. Computed tomography (CT) showed a large tumor in the right ovarian field. Brief recommendations 
regarding that issue based on the available literature has been summarized as well.
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INTRODUCTION
The colon cancer (CC) is the fourth most common can-
cer in the world. About 576,000 men and 521,000 wom-
en, respectively, are projected to be diagnosed with CC 
in 2018.  This incidence constitutes a 1.51% cumulative 
risk of CC among men aged 0–74 years, and a 1.12% risk 
among women. [1]. CC is associated with metastatic spread 
in 50% of cases in the course of disease [2]. Common sites 
for synchronous metastases from colorectal cancer are the 
lung, liver, peritoneum, bone and brain [3]. The frequency 
of ovarian metastasis from CC varies widely from 1.6 to 
7.4% (the rate of ovarian metastases from CC is reported to 
be up to 30%, but this refers to autopsy patients who died 
from CC). This type of metastasis is difficult to distinguish 
clinically from primary ovarian neoplasms — even up to 
45% of CC metastases are clinically mistaken for primary 
ovarian tumors. The optimal first-line treatment strategy is 
debatable [3–6].
CASE REPORT
We present a case of a 49-years old woman admitted 
to the Department of General Surgery at the 5th Military 
Clinical Hospital in Cracow for elective surgery for metastatic 
obstructive sigmoid cancer.
She was diagnosed with a growing tumor in the meso- 
and hypogastric area and abdominal pain. Computed to-
mography (CT) showed a large tumor (15 × 11 × 9 cm) in the 
right ovarian field (Fig.1). CT also confirmed the presence 
of the sigmoid wall thickening on the section about 7 cm 
long with blurred borders. Furthermore, numerous minor 
liver lesions were noted, most likely metastatic on imaging. 
Colonoscopy revealed in the sigmoid (18 cm upwards 
from the anal sphincter) a circular obstructive infiltrate im-
pervious to the endoscope. Biopsy specimen on histopathol-
ogy confirmed the diagnosis of adenocarcinoma.
Due to impending bowel obstruction patient was sched-
uled for primary resection of sigmoid with further systemic 
therapy afterwards. On admission patient was in good gen-
eral condition, no vomiting, normosthenic, without signs 
of cachexia (normal total protein and albumin level); ab-
dominal wall arched at the level of the chest, with tumor 
palpable in the right iliac fossa, no peritoneal signs and 
normal peristalsis. Laboratory tests found mild anemia (HGB 
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10.8 g/dL) and elevated tumor markers (CEA 11 ng/mL, Ca 
19–9 125 IU/mL, Ca 125 362,2 IU/mL).
Intraoperatively, the right and centrally located 
25 × 15 cm tumor was found, as well as the lower sigmoid 
tumor of 5–6 cm in size, significantly narrowing the intestinal 
lumen. Additionally, multiple neoplastic seeds were noted 
in the pouch of Douglas and massive metastatic lesions of 
both liver lobes. Surgery was performed as planned (sigmoid 
resection with primary anastomosis); additionally, liver me-
tastasis biopsy was done. Remnant of the right ovary and 
right oviduct extensively infiltrated by the tumor were noted 
and resected en bloc as well. Clinical diagnosis of metastasis 
to the right ovary was seen. Postoperative course was un-
eventful, and the patient was discharged home.
Final histopathological report confirmed the diagnosis 
of sigmoid cancer (G2 adenocarcinoma pT3 N0 M1a). The in-
filtration to the right ovary was metastatic, while the sample 
taken from the liver was non-diagnostic on histopathology. 
DISCUSSION
Apart from primary ovarian malignancies, which warrant 
appropriate gynecological diagnostic work-up, ovaries are 
also relatively common site of secondary tumors. According 
to Yvonne et al., metastasis to the ovary accounted for 15% 
of all ovarian malignancies identified and the gastrointes-
tinal tract was the most common primary site (39%) [11]. 
During the initial laparotomy, up to 3.4–10.3% of patients 
with CC are found to have synchronous metastases to the 
ovary [6]. An analysis by Segelman et al. [13], (> 3000 pa-
tients with CC) reported total incidence rate of synchronous 
ovarian metastases reaching 1.1%. Main results of this study 
are shown in Table 1. Metastases are commonly bilateral 
on presentation and usually not larger than 10 cm in its 
largest dimension [6, 10, 11] — on the contrary of the case 
presented here (15 cm). They are also more commonly seen 
in premenopausal women [10].  
The process by which CC metastasizes more frequently 
to the ovary versus other intraabdominal organs is still not 
clearly explained. Some theories suggest hematogenous 
spread or contact dissemination (migration of malignant 
cells through peritoneal space) [3].
Hematogenous pathway is convergent with the fact 
that some authors indicate that a younger premenopausal 
female which has higher blood flow to the premenopausal 
ovary present more often with ovarian metastasis [4, 6, 8].
The optimal treatment for ovarian metastasis from CC 
depends on the advancement of disease, whether soli-
tary metastasis or multiple foci are present, general status 
of the patient and numerous other clinical factors. Mul-
tidisciplinary approach is mandatory to include at least 
gynecologists, surgeons and medical oncologists in the 
decision process. Some recommend surgery for metastatic 
ovarian lesion if resectable [3]. It is claimed that even if only 
one ovary is involved, bilateral oophorectomy should be 
performed, as autopsy series frequently shows bilateral 
ovarian involvement on the histopathology despite being 
clinically limited to one ovary only [6, 9]. The prognosis is 
generally poor and long-term survival has been reported 
relatively rare, as ovarian involvement reflects massively 
advanced disease with microscopic intraperitoneal spread 
(even if clinically negative on inspection). In CC the detec-
tion rate of malignant cells in peritoneal effusion has been 
reported as 1.4–35.5%. Due to the wide range of cytologic 
positivity rate for malignant cells in peritoneal effusion, 
cytologic evaluation of peritoneal fluid is not routinely 
performed, thus peritoneal fluid has not been regarded 
as a reliable indicator [12]. The median survival in patients 
with residual disease after ovariectomy for metastasis is 
10 months. [3 ,6]. A better prognosis have females with-
out concomitant peritoneal spread. According to Miller 
et al., they had median survival time 25.2 months versus 
10.8 months [6, 8, 10]. Considering generally poor prognosis 
some authors suggested palliative surgical management 
only or emergency surgery, leaving the patient mainly to 
systemic therapy or best supportive care if not fit enough 
or with very limited expected survival [6].
Table 1. Incidence of metastases to the ovary in patients with CC 
according to Segelman et al. [13], 2010
No. of metastases to the ovary in patients with CC (%)
Synchronous Metachronous
34/3712 (1.1%) 22/1971 (1.1%)
CC — colon cancer
Figure 1. Computed tomography showed a large tumor in the right 
ovarian field
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Due to impending bowel obstruction, this particular 
patient was scheduled for primary resection of sigmoid 
with further systemic therapy afterwards, however in the 
non-urgent settings an International Ovarian Tumor Analysis 
protocol is recommended [14].
The concept of prophylactic ovariectomy in patients 
with CC, described in the past literature, resulted from ob-
served clinical predilection of CC to metastasize to the ova-
ries. However, there are only a few evidence-based data 
concerning this issue with conclusions which did not sup-
ported the rationale for prophylactic ovariectomy [15]. It 
seems that prophylactic adnexectomy does not provide any 
additional benefit [16, 17]. Brief recommendations regarding 
that issue based on the available literature has been sum-
marized in the Table 2.
CONCLUSION
We conclude that a female patient, especially in the pre-
menopausal age with a mass in the ovarian region, should 
always be also diagnosed for ovarian metastasis deriving 
from other intraabdominal malignancies. Surgeons and 
gynecologists who had diagnosed an ovarian metastasis 
from an unknown origin should keep in mind that the CC 
is most likely the primary tumor. Multidisciplinary approach 
is mandatory, as the optimal treatment might encompass 
gynecologists, surgeons and medical oncologists. Family 
history taking can be helpful during diagnostic process, with 
particular focus on hereditary syndromes with increased 
colon cancer risk — including Hereditary Non Polyposis 
Colorectal Cancer (HNPCC) and Familial Adenomatous Poly-
posis (FAP), as well as inflammatory bowel diseases (Crohn’s 
disease, ulcerative colitis) which as well increase the risk of 
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Table 2. General remarks on ovarian metastasis from colon cancer
General remarks on ovarian metastasis from CC
1. Prophylactic excision and collection of tissue samples of normal-appearing ovaries in patients with CC is neither necessary nor supported by data.
2. Clinical suspicion of ovarian metastasis requires detailed inspection of the entire abdominal cavity in the search of other primary or secondary tumors.
3.
 After ruling-out other than ovarian intraabdominal seeds which could not be radically resected/ablated and following radical resection of 
colon segment with primary focus, unilateral (in premenopausal women, involving the diseased ova-
ry) or bilateral (in postmenopausal women, involving the diseased and the contralateral healthy ovary) ovariectomy is justified.
4. Ovariectomy with metachronic metastases from CC  is warranted if primary or secondary excision or ablation of other extragonadal disease lesions is possible.
5.
Different guidelines apply to patients with CC who have hereditary syndromes like HNPCC, Lynch syndrome, Peutz-Jeghers  syndrome and 
BRCA1 and BRCA2 gene mutation-associated syndromes. In this case, the risk of primary ovarian cancer is higher than in the general population, 
therefore these patients, in addition to treatment of CC, require an appropriate and comprehensive prophylactic plan, including the ovaries.
Based on: Wysocki W. et al. [16], 2013
CC — colon cancer
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